1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Derived from lung tissue, with its epithelioid morphology and adherent growth pattern,LK-2 cells exhibit squamous cell carcinoma characteristics and are notable for their low molecular weight thiol protease inhibitor production. Cultivate these epithelial-like cells in RPMI 1640 supplemented with 10% FBS under standard conditions of 37 ℃ and 5% CO2. LK-2 cells with a doubling time of approximately 27 hours, this cell line offers a dynamic platform for accelerated research.
Why choose LK-2 from AcceGen?
LK-2 cell line has been rigorously characterized by cell line characterization service to ensure the highest standards of cell line purity. The product is shipped with dry ice and should be stored in liquid nitrogen. The recommended LK-2 Complete Medium, meticulously formulated for optimal growth, guarantees consistent and robust cell performance. Propel your squamous cell carcinoma research to new heights with the LK-2 cell line – a beacon of innovation in the realm of cancer biology.
| Product Code | LK 2; LK2 |
| Species | Human |
| Cat.No | ABC-TC0587 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial-like |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Lung Cancer Cell Lines |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
FOR RESEARCH USE ONLY
Lung cancer is the leading cause of cancer-related to cancer worldwide. Squamous cell carcinoma (SCC) is a type of cancer that commonly originates in the squamous cells, which are thin, flat cells lining various organs, including the skin and mucous membranes. The study of SCC holds significant importance in scientific research across various domains. Here are some key applications of research on squamous cell carcinoma in science:
Cancer Biology and Pathogenesis: Understanding the molecular and cellular mechanisms underlying squamous cell carcinoma provides valuable insights into cancer biology. Researchers investigate the genetic mutations, signaling pathways, and immune responses associated with SCC, contributing to the broader knowledge of cancer development and progression.
Diagnostic and Prognostic Markers: Identification of specific biomarkers associated with squamous cell carcinoma aids in the development of diagnostic and prognostic tools. Detection of these markers helps in early diagnosis, enabling timely intervention and improved patient outcomes.
Therapeutic Approaches: Research on SCC informs the development of targeted therapies and treatment strategies. Investigating the molecular pathways involved in SCC allows scientists to explore novel therapeutic agents, leading to advancements in cancer treatment modalities.
Drug Discovery and Development: Squamous cell carcinoma research contributes to the discovery of new drugs and therapeutic targets. Investigating the vulnerabilities of cancer cells helps in the design and development of drugs that selectively target SCC cells while minimizing side effects on normal cells.
Precision Medicine: Personalized or precision medicine aims to tailor medical treatment to the individual characteristics of each patient. Research on SCC facilitates the identification of specific genetic alterations or biomarkers, paving the way for more targeted and effective therapeutic interventions.
Immunotherapy: SCC research plays a crucial role in the development of immunotherapeutic approaches. Understanding the tumor microenvironment and immune responses in squamous cell carcinoma guides the design of immunotherapies that harness the body’s immune system to combat cancer.
Clinical Trials: Insights gained from SCC research contribute to the design and implementation of clinical trials. These trials evaluate the safety and efficacy of new treatments, helping to bring innovative therapies from the laboratory to the clinic.
Public Health and Education: Knowledge generated from squamous cell carcinoma studies contributes to public health awareness and education. Understanding risk factors, early symptoms, and preventive measures helps educate the public and healthcare professionals, leading to better disease management and prevention.
